| A year-long extended release nanoformulated cabotegravir prodrug TA Kulkarni, AN Bade, B Sillman, BLD Shetty, MS Wojtkiewicz, N Gautam, ... Nature materials 19 (8), 910-920, 2020 | 83 | 2020 |
| Lipophilic nanocrystal prodrug-release defines the extended pharmacokinetic profiles of a year-long cabotegravir N Gautam, JEM McMillan, D Kumar, AN Bade, Q Pan, TA Kulkarni, W Li, ... Nature communications 12 (1), 3453, 2021 | 37 | 2021 |
| A fully integrated online platform for real time monitoring of multiple product quality attributes in biopharmaceutical processes for monoclonal antibody therapeutics Y Liu, C Zhang, J Chen, J Fernandez, P Vellala, TA Kulkarni, I Aguilar, ... Journal of Pharmaceutical Sciences 111 (2), 358-367, 2022 | 36 | 2022 |
| Non-viral vectors for delivery of nucleic acid therapies for cancer S Kanvinde, T Kulkarni, S Deodhar, D Bhattacharya, A Dasgupta BioTech 11 (1), 6, 2022 | 21 | 2022 |
| The immunopathobiology of SARS-CoV-2 infection M Patel, F Shahjin, JD Cohen, M Hasan, J Machhi, H Chugh, S Singh, ... FEMS Microbiology Reviews 45 (6), fuab035, 2021 | 14 | 2021 |
| Non-viral gene therapy vectors for cancer treatment S Kanvinde, T Kulkarni, S Deodhar, D Bhattacharya, A Dasgupta Preprints, 2022 | 1 | 2022 |
| Nanotherapeutic Approaches to Treat COVID-19-Induced Pulmonary Fibrosis S Kanvinde, S Deodhar, TA Kulkarni, CM Jogdeo BioTech 12 (2), 34, 2023 | | 2023 |
| Nano-Therapeutic Approaches to Treat COVID Induced Pulmonary Fibrosis (preprint) S Kanvinde, S Deodhar, TA Kulkarni, CM Jogdeo | | 2023 |
| Development of Once-A-Year Injectable Formulation of Cabotegravir for Prevention and Treatment of HIV Infection TA Kulkarni | | 2021 |
| Development, Formulation and Evaluation of 5 Fluorouracil Tablet as a Viable Colon Targeted Drug Delivery System using Compression Coat of Polymer (s) MP Bhandarwad, SS Deodhar, TA Kulkarni, TA Shaikh, AD Savkare | | |
